Acetazolamide
- Product NDC
- 62135-612
- 11-digit product format
- 621350612
- Labeler code
- 62135
- Product ID
- 62135-612_2420ae6d-8967-ef58-e063-6394a90a9656
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Acetazolamide
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Chartwell RX, LLC
- Application
- ANDA040904
- Marketing category
- ANDA
- Marketing start
- 2021-02-15
- Substance
- ACETAZOLAMIDE
- Active strength
- 500 mg/1
- Pharmacologic classes
- Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Acetazolamide
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ACETAZOLAMIDE | 500 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | O3FX965V0I |
| Rxcui | 562524 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 62135-612-60 | Acetazolamide | 60 in 1 PACKAGE | CAPSULE, EXTENDED RELEASE | 60 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 62135-612 | ACETAZOLAMIDE CAPSULE, EXTENDED RELEASE [CHARTWELL RX, LLC] | 2 | Current NDC, 1 package rows | 20241012_e8e48a25-5f6c-4b5a-a5f2-ee87aabea33b.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 62135-612-60 | 62135061260 | 60 CAPSULE, EXTENDED RELEASE in 1 PACKAGE (62135-612-60) | 2023-05-09 | No | No | Historical |